James Thorp et al.'s research: COVID mRNA technology's Catastrophic impact on Pregnancy Outcomes & Menstrual Function; miscarriage, fetal chromosomal abnormalities, fetal malformation, fetal cystic

hygroma, cardiac disorders, arrhythmia, cardiac arrest, vascular mal-perfusion, growth abnormalities, fetal abnormal surveillance, fetal placental thrombosis, low amniotic fluid, and fetal death/still

SOURCE:

COVID-19 Vaccines: The Impact on Pregnancy Outcomes and Menstrual Function[v1] | Preprints.org

Population based retrospective cohort study. Setting: US and global entries in US Centers for Disease Control and Prevention (CDC) Vaccine Adverse Events Reporting System (VAERS).

Participants:

CDC VAERS entries from January 1, 1998 to June 30, 2022.

Main Outcome and Measures:

A proportional reporting ratio analysis is performed using data in the VAERS system comparing adverse events (AE) reported post COVID-19 vaccines with that of post-Influenza vaccines.

Results:

COVID-19 vaccines, when compared to the Influenza vaccines are associated with a significant increase in AE with all proportional reporting ratios of > 2.0:

menstrual abnormality, miscarriage, fetal chromosomal abnormalities, fetal malformation, fetal cystic hygroma, fetal cardiac disorders, fetal arrhythmia, fetal cardiac arrest, fetal vascular mal-perfusion, fetal growth abnormalities, fetal abnormal surveillance, fetal placental thrombosis, low amniotic fluid, and fetal death/stillbirth (all p values were much smaller than 0.05). When normalized by time-available, doses-given, or persons-received, all COVID-19 vaccine AE far exceed the safety signal on all recognized thresholds.

Conclusions:

Pregnancy and menstrual abnormalities are significantly more frequent following COVID-19 vaccinations than that of Influenza vaccinations.’